Try GOLD - Free
Budget 2026 must boost R&D activity
Business Standard
|January 08, 2026
Innovative activity is widely recognised as a key driver of competitiveness and economic growth.
Its importance has only increased in the context of the artificial intelligence (Al) revolution and the compulsions of net-zero. Hence, India’s underperformance in gross research & development (R&D) expenditure (GERD) as aproportion of gross domestic product — stagnating at around 0.7 per cent, much lower than the global average of 1.93 per cent — has attracted much debate. Other countries like China spend a far higher proportion on R&D, at about 2.6 per cent.
The output indicators of innovative activity — for example, India’s rank improving from 81st to 38th between 2015 and 2025 in the World Intellectual Property Organization’s Global Innovation Index—present a more encouraging picture. Patents filed in India have also surged, from 24,326 in 2020-21 to 68,176 in 2024-2S. ISID’s India Industrial Development Report 2024-25 finds India’s GERD to be underestimated and projects it at around 1.25 per cent — more respectable than 0.7 per cent, but still low.
Another concern about GERD is that over 60 per cent of it is spent not by business enterprises, where it could help sharpen their competitive edge, but in government laboratories, including those run by the Council ofScientific & Industrial Research, the Defence Research and Development Organisation, and the Indian Council of Medical Research, among others. While mission-oriented R&D organisations such asthe Indian Space Research Organisation have achieved considerable success, government laboratories often face challenges in commercialising their innovations.
This story is from the January 08, 2026 edition of Business Standard.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Business Standard
Business Standard
Labour Codes impact: HCL tech profit slips 11%
Q3 top line beats Street estimates, bottom line misses expectations
2 mins
January 13, 2026
Business Standard
New labour Codes, restructuring weigh on TCS earnings
Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.
1 min
January 13, 2026
Business Standard
Black drives the thrill for car buyers
Sees a surge in yearly sales, while white remains practical 'utility king'
2 mins
January 13, 2026
Business Standard
CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS
Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be
2 mins
January 13, 2026
Business Standard
China’s PVC rethink to help India pipe makers
Supply likely to tighten after S-PVC rebate withdrawal
2 mins
January 13, 2026
Business Standard
Responsible growth
India must ensure data centres are sustainable
2 mins
January 13, 2026
Business Standard
India’s GenZ is full of creativity: PM
Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.
1 min
January 13, 2026
Business Standard
Iran wants to negotiate after threats to attack, says Trump
At least 572 killed in protests; Tehran says situation ‘under full control’
2 mins
January 13, 2026
Business Standard
Insurers knock on Irdai door for clarity on director overlap ban
CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY
2 mins
January 13, 2026
Business Standard
Delhi HC allows Zydus to sell generic version of cancer drug
Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.
1 min
January 13, 2026
Listen
Translate
Change font size
